I was in love with Drugstore.com (DSCM) about this time last year. While hunting for undervalued stocks using the MSN Stock Screener I noticed that the stock was low compared to its 52-week high. I’ve found many cheap stocks using that formula – 52-week high greater than $5, current price under $2 (or $2.50 & $4 I think was the case here).
I bought the stock last year in early Summer 2007 at $2.45 because I noticed the stock always climbs in the second half of the year and then crashes. I guessed correctly that it was about to climb, cashing out a few months later when it reached $3.40.
I always thought the stock had strong visibility, which is crucial for a dotcom, and I even ordered some bath products on their site before investing, just to make sure the company wasn’t a complete mess.
This year, however, I’m unsure of this company.
The price fell after the Q4 peak just as it does every year. Right now its sitting at around $2.30. My worry is that this year it won’t climb back up.
They just changed out some of their key company executives, they announced a net loss for yet another year, and the company CEO is more concerned with being appointed to the New York Times board.
Key executive changes happen, but what kind of web company operates in the red these days? Its not 1999 anymore. How hard is it to make a profit in online retail? Of course, I know the answer. One of my long-time web clients, 1-800-luggage.com, went out of business last year after being squeezed off the web by major industry players (like eBags, who strongarms their vendors into sub-wholesale prices). Just goes to show, profit is crucial to survival.
However, Drugstore is called the #1 online Health and Beauty site. Their Alexa ranking is around 5,000, which puts it at the top of the web. These should be positive things for profit. Their annual report just came out today showing they had a 10% increase in sales. It didn’t say how much more these new sales cost though. If they are still in the red, I’m guessing their cost per sale is rising faster than their increase in sales.
Zacks.com bumped the stock up to a BUY today, which helped raise it a few pennies. They say “DSCM shares trade at a discount.” Read here:
DSCM shares trade at a discount to its industry peers based on price-to-sales and price-to-book ratios. Note: the company has no earnings and, thus, no price-to-earnings multiple. In our view, the company’s lack of profits and difficult competitive environment warrant a discount valuation relative to its peers. That said, with the company moving closer to becoming profitable, its stock should still be able to trade at a price-to-sales multiple of 0.9x our 2008 sales estimate. We reiterate our Buy rating on the stock. We also maintain our $4.50 target price, which is derived using a price-to-sales ratio of 0.9x.
(more here – Discount Makes DSCM a Buy)
One nice thought that is being kicked around is an acquisition of Drugstore.com by eBay. I don’t know if this is just rumor, but it would obviously turn a buy into a nice return.
Drugstore.com stock has performed well for me in the past. They are probably just seeing some rough days. In the end, the financials really don’t matter because investors seem to buy every retailer in the 3rd quarter. As long as Drugstore.com doesn’t do anything completely stupid, the stock profits will come again this year.
Filed under: Investing, money, Stocks, technology | Tagged: business, discount, dotcom, drugstore, ebay, money | 1 Comment »